+ Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.
-
Upload
clarence-richard -
Category
Documents
-
view
216 -
download
3
Transcript of + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.
![Page 1: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/1.jpg)
+
Clinical Decision on a Diagnostic Test
Inna Mangalindan. Block N. Class 2009.
September 15, 2008
![Page 2: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/2.jpg)
+Salient Features
R.E.
25/F
Presenting with R flank pain radiating to the R inguinal area, hematuria, and frequency
![Page 3: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/3.jpg)
+Differential Diagnosis
Urolithiasis (pretest probability of 60%) R flank pain radiating to the R inguinal area Hematuria Frequency
Acute Uncomplicated Cystitis (pretest probability of 30%) Hematuria Frequency
Acute Appendicitis (pretest probability of 2%) R flank pain (a remote possibility)
![Page 4: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/4.jpg)
+Review
Decision threshold Based on your own clinical judgment
Pretest Probability Based on prevalence studies
![Page 5: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/5.jpg)
+
UROLITHIASIS Decision Threshold: 5%-75%
5% (lower limit) – below which, send pt home and do nothing
75% (upper limit) – start treatment Pretest Probability: 60%
This falls in between 5 and 75% so we cannot start treatment right away nor send the patient home. Therefore, we need further diagnostic testing.
0% 5% 75%
60% Urolithiasis
![Page 6: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/6.jpg)
+
ACUTE UNCOMPLICATED CYSTITIS Decision Threshold: 5%-40%
5% (lower limit) – below which, send pt home and do nothing
40% (upper limit) – start treatment (Ofloxacin 200mg BID x 3 days)
Pretest Probability: 30% This falls in between 5 and 40% so we cannot start
treatment right away nor send the patient home. Therefore, we need further diagnostic testing.
0% 5% 40%
30% Acute Uncomplicated Cystitis
![Page 7: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/7.jpg)
+
ACUTE APPENDICITIS Decision Threshold: 5%-90%
5% (lower limit) – below which, send pt home and do nothing
90% (upper limit) – start treatment (appendectomy) Pretest Probability: 2%
There is no need for further diagnostic testing in this case because it is below our 5% limit.
0% 5% 90%
2% Acute Appendicitis
![Page 8: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/8.jpg)
+What Influences our Decision Thresholds: A Review
Physician expertise
Health system
Intervention
Prior experience
Patient preference
![Page 9: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/9.jpg)
+Diagnostic Options for Urolithiasis
KUB (Kidney, Ureter, Bladder) Ultrasound
Intravenous Pyelography
![Page 10: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/10.jpg)
+Diagnostic Dilemma
What is the sensitivity and specificity of KUB Ultrasound vs Intravenous Pyelography in diagnosing Urolithiasis using Cross-Sectional Studies?
![Page 11: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/11.jpg)
+
![Page 12: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/12.jpg)
+
![Page 13: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/13.jpg)
+
![Page 14: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/14.jpg)
+
![Page 15: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/15.jpg)
+
![Page 16: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/16.jpg)
+
![Page 17: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/17.jpg)
+
![Page 18: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/18.jpg)
+
![Page 19: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/19.jpg)
+
![Page 20: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/20.jpg)
+
![Page 21: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/21.jpg)
+
CRITICAL APPRAISALIs the study valid?
![Page 22: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/22.jpg)
+PRIMARY VALIDITY GUIDES
1. Was there an independent and blind comparison with a reference standard?
YES. All of the 108 patients enrolled in the study first underwent KUB-UTZ then Intravenous Pyelography (the criterion standard).
A reference standard for a diagnostic test is the test that gives the information nearest to the “truth”. Thus the accuracy of the test should be compared against the standard.
![Page 23: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/23.jpg)
+PRIMARY VALIDITY GUIDES
2. Did the patient sample include the spectrum of patients to whom the test will be applied in practice?
YES. The patients enrolled in the study were adult patients between the ages of 18 and 65 years presenting with unilateral flank pain and hematuria who presented at the Emergency Department.
The patient in our case was a 25-year-old female, presenting with R flank pain and hematuria, who went for consult at AMBU.
The accuracy of a diagnostic test among patients with low risk for the disease is different from patients with high risk of the disease.
![Page 24: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/24.jpg)
+SECONDARY VALIDITY GUIDES
3. Was the reference standard done regardless of the result of the diagnostic test being evaluated?
YES. All 108 patients included in the study underwent both KUB-UTZ and Intravenous Pyelography regardless of the result of each test.
VERIFICATION BIAS: In some studies, the reference standard (in this case, IVP) is only done based on the initial result of the diagnostic test (KUB-UTZ) in order to verify the initial finding, i.e., when positive. When this happens, most of the data available will be those positive for the diagnostic test and the reference standard. This will increase the accuracy of the test.
![Page 25: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/25.jpg)
+SECONDARY VALIDITY GUIDES
4. Were the methods for performing the test described in sufficient detail to permit replication?
YES. The procedures (KUB-Ultrasound and IVP) were described in detail in the methods section.
![Page 26: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/26.jpg)
+OVERALL, IS THE STUDY VALID?
YES. Most of the questions were answered adequately.
![Page 27: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/27.jpg)
+CRITICAL APPRAISAL
What are the results?
![Page 28: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/28.jpg)
+RESULTS
1. What were the likelihood ratios for the different possible test results?
Likelihood ratios indicate by how much a given test result increases the pre-test probability of the disease.
5%0% 75%
60% Urolithiasis
![Page 29: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/29.jpg)
+Likelihood Ratios for the Diagnostic Test (KUB-UTZ)
Positive Test
LR (+) = Sn/1-Sp 0.971 / (1 – 0.589) 0.971 / 0.411 2.363
Negative Test
LR (-) = 1-Sn/Sp (1 – 0.971) / 0.589 0.029 / 0.589 0.049
![Page 30: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/30.jpg)
+Nomogram for interpreting diagnostic test results (Likelihood ratio)
In this nomogram, a straight line drawn from a patient's pre-test probability of disease (which is estimated from experience, local data or published literature) through the LR for the test result that may be used, will point to the post-test probability of disease.
![Page 31: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/31.jpg)
+Post-test Probabilities after KUB-UTZ
82% now falls on the decision to treat limit. Therefore, a positive KUB-UTZ result can boost your decision to start treatment already.
However, a negative KUB-UTZ result is not enough to make you decide to send your patient home because it is still above the lower limit of our decision threshold.
60% Urolithiasis
0% 5% 75%
7% 82%
(-) (+)
![Page 32: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/32.jpg)
+
CRITICAL APPRAISALWill the results help me in caring for my patients?
![Page 33: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/33.jpg)
+
Will the reproducibility of the test result and its interpretation be satisfactory in my setting?
YES. KUB-UTZ is widely used in our setting. It was also adequately described in the study and its interpretation was definite and simple.
![Page 34: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/34.jpg)
+
Are the results applicable to my patient?
YES. Patients included in the study are those between the ages of 18 and 65 years who presented at the Emergency Department with unilateral flank pain and hematuria.
Our patient is a 25-year-old female who presented at AMBU with R flank pain, hematuria, and frequency.
![Page 35: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/35.jpg)
+
Will the results change my management?
YES. If the KUB-UTZ is positive, the post-test probability increases to 82%, which falls into the range for a decision to start treatment.
![Page 36: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/36.jpg)
+
Will patients be better off as a result of the test?
YES. Doing the test will help us in deciding whether to start treatment.
![Page 37: + Clinical Decision on a Diagnostic Test Inna Mangalindan. Block N. Class 2009. September 15, 2008.](https://reader030.fdocuments.in/reader030/viewer/2022032805/56649ee15503460f94bf2595/html5/thumbnails/37.jpg)
+Resolution of the Problem in the Scenario
KUB-UTZ has a high sensitivity and can be used as an effective screening tool in the evaluation of adult patients presenting with unilateral flank pain and hematuria.